| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 6 |
| 1 | PREDNISOLONE ORAL | 6 |
| 2 | PREDNISOLONE ORAL SOLUTION | 6 |
| 3 | RITUXIMAB | 6 |
| 4 | OCRELIZUMAB | 5 |
| 5 | ACETAMINOPHEN | 2 |
| 6 | ACETAMINOPHEN 500MG | 2 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 8 | PAIN RELIEVER | 2 |
| 9 | ATOVAQUONE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UBLITUXIMAB | 1 | 0.0003 |
| 1 | ATOVAQUONE | 1 | 0.0001 |
| 2 | OXYBUTYNIN CHLORIDE | 1 | 0.0001 |
| 3 | CHOLESTYRAMINE | 1 | 0.0001 |
| 4 | OCRELIZUMAB | 5 | 0.0001 |
| 5 | LOPERAMIDE HCL | 1 | 0.0001 |
| 6 | KETOCONAZOLE FOAM | 1 | 0.0001 |
| 7 | KETOCONAZOLE CREAM, 2% | 1 | 0.0001 |
| 8 | MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE | 1 | 0.0001 |
| 9 | KETOCONAZOLE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 1 | Corticosteroid [EPC] | 6 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 3 | Alkylating Drug [EPC] | 1 |
| 4 | Antimalarial [EPC] | 1 |
| 5 | Antiprotozoal [EPC] | 1 |
| 6 | Atypical Antipsychotic [EPC] | 1 |
| 7 | Azole Antifungal [EPC] | 1 |
| 8 | BCL-2 Inhibitor [EPC] | 1 |
| 9 | Bile Acid Sequestrant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 1 | 0.0001 |
| 1 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 12 | 0.0000 |
| 4 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 6 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 6 | 0.0000 |